Table of Contents Author Guidelines Submit a Manuscript
Cardiology Research and Practice
Volume 2010, Article ID 642045, 8 pages
http://dx.doi.org/10.4061/2010/642045
Clinical Study

Additive Value of B-Type Natriuretic Peptide on Rest -Dipyridamole Stress -Sestamibi Gated Myocardial SPECT in Patients with Normal Left Ventricular Systolic Function

1Department of Internal Medicine, Inje University College of Medicine, Busan 614-735, South Korea
2Department of Internal Medicine, Seoul National University College of Medicine, Seoul 156-707, South Korea
3Cardiovascular Center, Seoul National University Bundang Hospital, Seoul 110-799, South Korea
4Seoul National University Boramae Medical Center, Seongnam-si, Gyeonggi-do 463-707, South Korea
5Cardiovascular Center, Seoul National University Boramae Medical Center, Shindaebang 2-Dong 425, Dongjak-Gu, Seoul 110-779, South Korea
6Cardiovascular Center, Seoul National University Hospital, Seoul 110-799, South Korea

Received 30 September 2009; Revised 1 February 2010; Accepted 8 February 2010

Academic Editor: Christian Wilhelm Hamm

Copyright © 2010 Jung-Ju Sir et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. S. Sabatine, D. A. Morrow, J. A. de Lemos et al., “Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia,” Journal of the American College of Cardiology, vol. 44, no. 10, pp. 1988–1995, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. R. S. Foote, J. D. Pearlman, A. H. Siegel, and K. T. Yeo, “Detection of exercise-induced ischemia by changes in B-type natriuretic peptides,” Journal of the American College of Cardiology, vol. 44, no. 10, pp. 1980–1987, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Palazzuoli, L. Gennari, P. Calabria et al., “Relation of plasma brain natriuretic peptide levels in non-ST-elevation coronary disease and preserved systolic function to number of narrowed coronary arteries,” American Journal of Cardiology, vol. 96, no. 12, pp. 1705–1710, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Sahinarslan, A. Cengel, K. Okyay et al., “B-type natriuretic peptide and extent of lesion on coronary angiography in stable coronary artery disease,” Coronary Artery Disease, vol. 16, no. 4, pp. 225–229, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. J. P. Goetze, C. Christoffersen, M. Perko et al., “Increased cardiac BNP expression associated with myocardial ischemia,” The FASEB Journal, vol. 17, no. 9, pp. 1105–1107, 2003. View at Google Scholar · View at Scopus
  6. J. P. Goetze, A. Gore, C. H. Moller, D. A. Steinbruchel, J. F. Rehfeld, and L. B. Nielsen, “Acute myocardial hypoxia increases BNP gene expression,” The FASEB Journal, vol. 18, no. 15, pp. 1928–1930, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Weber, T. Dill, R. Arnold et al., “N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris,” American Heart Journal, vol. 148, no. 4, pp. 612–620, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Kragelund, B. Gronning, L. Kober, P. Hildebrandt, and R. Steffensen, “N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease,” New England Journal of Medicine, vol. 352, no. 7, pp. 666–675, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Bibbins-Domingo, M. Ansari, N. B. Schiller, B. Massie, and M. A. Whooley, “B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the heart and soul study,” Circulation, vol. 108, no. 24, pp. 2987–2992, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Staub, C. Nusbaumer, M. J. Zellweger et al., “Use of B-type natriuretic peptide in the detection of myocardial ischemia,” American Heart Journal, vol. 151, no. 6, pp. 1223–1230, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Zaid, A. Tanchilevitch, E. Rivlin et al., “Diagnostic accuracy of serum B-type natriuretic peptide for myocardial ischemia detection during exercise testing with Spect perfusion imaging,” International Journal of Cardiology, vol. 117, no. 2, pp. 157–164, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. F. J. Klocke, M. G. Baird, B. H. Lorell et al., “American College of Cardiology; American Heart Association; American Society for Nuclear Cardiology. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging),” Journal of the American College of Cardiology, vol. 42, no. 7, pp. 1318–1333, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. S.-S. Yao and A. Rozanski, “Principal uses of myocardial perfusion scintigraphy in the management of patients with known or suspected coronary artery disease,” Progress in Cardiovascular Diseases, vol. 43, no. 4, pp. 281–302, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. A. F. Parisi, P. M. Hartigan, and E. D. Folland, “Evaluation of exercise thallium scintigraphy versus exercise electrocardiography in predicting survival outcomes and morbid cardiac events in patients with single- and double-vessel disease: findings from Angioplasty Compared to Medicine (ACME) study,” Journal of the American College of Cardiology, vol. 30, no. 5, pp. 1256–1263, 1997. View at Publisher · View at Google Scholar · View at Scopus
  15. F. J. T. Wackers, “Artifacts in planar and SPECT myocardial perfusion imaging,” American Journal of Cardiac Imaging, vol. 6, no. 1, pp. 42–57, 1992. View at Google Scholar · View at Scopus
  16. J. Stolzenberg and R. London, “Reliability of stress thallium-201 scanning in the clinical evaluation of coronary artery disease,” Clinical Nuclear Medicine, vol. 4, no. 6, pp. 225–228, 1979. View at Google Scholar · View at Scopus
  17. R. Hachamovitch, D. S. Berman, L. J. Shaw et al., “Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction,” Circulation, vol. 97, no. 6, pp. 535–543, 1998. View at Google Scholar · View at Scopus
  18. C. Bionda, C. Bergerot, D. Ardail, C. Rodriguez-Lafrasse, and R. Rousson, “Plasma BNP and NT-proBNP assays by automated immunoanalyzers: analytical and clinical study,” Annals of Clinical and Laboratory Science, vol. 36, no. 3, pp. 299–306, 2006. View at Google Scholar · View at Scopus
  19. A. Clerico and M. Emdin, “Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review,” Clinical Chemistry, vol. 50, no. 1, pp. 33–50, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. S. J. Wieczorek, A. H. B. Wu, R. Christenson et al., “A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation,” American Heart Journal, vol. 144, no. 5, pp. 834–839, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Y. Wong, S. McSwiggan, N. S. Kennedy, R. S. MacWalter, and A. D. Struthers, “B-type natriuretic peptide identifies silent myocardial ischaemia in stroke survivors,” Heart, vol. 92, no. 4, pp. 487–489, 2006. View at Publisher · View at Google Scholar · View at Scopus